Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

Low iron levels are linked to hair loss in women.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Hair loss linked to higher heart disease risk in both men and women.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.